These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36489580)

  • 1. Privies and Vaults.
    Halls J Health; 1875 Apr; 22(4):118. PubMed ID: 36489580
    [No Abstract]   [Full Text] [Related]  

  • 2. Hookworm Due to Surface Privies and Lack of Privies.
    Tex Med J (Austin); 1909 Dec; 25(6):239-240. PubMed ID: 36956788
    [No Abstract]   [Full Text] [Related]  

  • 3. The parity of privies: summary research on privies in North Carolina.
    Carnes-McNaughton LF; Harper TM
    Hist Archaeol; 2000; 34(1):97-110. PubMed ID: 17896449
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes.
    Kedersha NL; Miquel MC; Bittner D; Rome LH
    J Cell Biol; 1990 Apr; 110(4):895-901. PubMed ID: 1691193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaults bind directly to microtubules via their caps and not their barrels.
    Eichenmüller B; Kedersha N; Solovyeva E; Everley P; Lang J; Himes RH; Suprenant KA
    Cell Motil Cytoskeleton; 2003 Dec; 56(4):225-36. PubMed ID: 14584025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vault mobility depends in part on microtubules and vaults can be recruited to the nuclear envelope.
    van Zon A; Mossink MH; Houtsmuller AB; Schoester M; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
    Exp Cell Res; 2006 Feb; 312(3):245-55. PubMed ID: 16310186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MVP and vaults: a role in the radiation response.
    Lara PC; Pruschy M; Zimmermann M; Henríquez-Hernández LA
    Radiat Oncol; 2011 Oct; 6():148. PubMed ID: 22040803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange.
    Yang J; Kickhoefer VA; Ng BC; Gopal A; Bentolila LA; John S; Tolbert SH; Rome LH
    ACS Nano; 2010 Dec; 4(12):7229-40. PubMed ID: 21121616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The faster, the better? Relationships between run-up speed, the degree of difficulty (D-score), height and length of flight on vault in artistic gymnastics.
    Schärer C; Lehmann T; Naundorf F; Taube W; Hübner K
    PLoS One; 2019; 14(3):e0213310. PubMed ID: 30845256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic-field exposures of cable splicers in electrical network distribution vaults.
    Bracken TD; Rankin RF; Senior RS; Kavet R; Geissinger LG
    Appl Occup Environ Hyg; 2001 Mar; 16(3):369-79. PubMed ID: 11297051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal transport of ribonucleoprotein particles (vaults).
    Li JY; Volknandt W; Dahlstrom A; Herrmann C; Blasi J; Das B; Zimmermann H
    Neuroscience; 1999; 91(3):1055-65. PubMed ID: 10391483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-in-one biofabrication and loading of recombinant vaults in human cells.
    Martín F; Carreño A; Mendoza R; Caruana P; Rodriguez F; Bravo M; Benito A; Ferrer-Miralles N; Céspedes MV; Corchero JL
    Biofabrication; 2022 Mar; 14(2):. PubMed ID: 35203066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaults engineered for hydrophobic drug delivery.
    Buehler DC; Toso DB; Kickhoefer VA; Zhou ZH; Rome LH
    Small; 2011 May; 7(10):1432-9. PubMed ID: 21506266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.
    Mikyas Y; Makabi M; Raval-Fernandes S; Harrington L; Kickhoefer VA; Rome LH; Stewart PL
    J Mol Biol; 2004 Nov; 344(1):91-105. PubMed ID: 15504404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular functions of vaults and their involvement in multidrug resistance.
    Steiner E; Holzmann K; Elbling L; Micksche M; Berger W
    Curr Drug Targets; 2006 Aug; 7(8):923-34. PubMed ID: 16918321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3'-ethynylcytidine, an RNA polymerase inhibitor, combined with cisplatin exhibits a potent synergistic growth-inhibitory effect via Vaults dysfunction.
    Fukushima H; Abe T; Sakamoto K; Tsujimoto H; Mizuarai S; Oie S
    BMC Cancer; 2014 Aug; 14():562. PubMed ID: 25087851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct visualization of vaults within intact cells by electron cryo-tomography.
    Woodward CL; Mendonça LM; Jensen GJ
    Cell Mol Life Sci; 2015 Sep; 72(17):3401-9. PubMed ID: 25864047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaults: a ribonucleoprotein particle involved in drug resistance?
    Mossink MH; van Zon A; Scheper RJ; Sonneveld P; Wiemer EA
    Oncogene; 2003 Oct; 22(47):7458-67. PubMed ID: 14576851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural stability of vault particles.
    Esfandiary R; Kickhoefer VA; Rome LH; Joshi SB; Middaugh CR
    J Pharm Sci; 2009 Apr; 98(4):1376-86. PubMed ID: 18683860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The formation of vault-tubes: a dynamic interaction between vaults and vault PARP.
    van Zon A; Mossink MH; Schoester M; Houtsmuller AB; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
    J Cell Sci; 2003 Nov; 116(Pt 21):4391-400. PubMed ID: 13130096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.